Skinject is developing a drug delivery system for the treatment of non-melanoma skin cancers. Its device comprises a dissolvable microneedle array (MNA) to deliver a drug directly into the top layer of the skin. SkinJect’s system can also be used for the treatment and prevention of squamous cell carcinoma and actinic keratosis.